Biomind Labs Inc.
BMND
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.50K | -66.80K | 172.30K | -34.50K | -212.10K |
| Total Depreciation and Amortization | 0.00 | 2.20K | 2.20K | 2.20K | 2.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.00K | -48.40K | -272.60K | -56.40K | 103.50K |
| Change in Net Operating Assets | 112.20K | 113.40K | -4.50K | -22.40K | 81.20K |
| Cash from Operations | 19.70K | 500.00 | -102.70K | -111.10K | -25.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 400.00 | -- | 84.70K | 55.80K | 77.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -5.10K | -- |
| Cash from Financing | 400.00 | -- | 84.70K | 50.70K | 77.60K |
| Foreign Exchange rate Adjustments | -19.90K | -500.00 | 8.00K | 37.40K | -21.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -44.50K |
| Net Change in Cash | 100.00 | 0.00 | -10.00K | -23.10K | -13.30K |